EFFECTS OF SYSTEMIC ADMINISTRATION OF 6-HYDROXYDOPAMINE, 6-HYDROXYDOPA AND 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROXYPYRIDINE (MPTP) ON TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS IN THE RAT

被引:20
作者
LIN, JY
MAI, LM
PAN, JT
机构
[1] NATL YANG MING MED COLL,INST PHYSIOL,TAIPEI 11221,TAIWAN
[2] NATL YANG MING MED COLL,DEPT ANAT,TAIPEI,TAIWAN
关键词
DOPAMINE; 6-HYDROXYDOPAMINE; 6-HYDROXYDOPA; MPTP; NEUROTOXIN; HPLC; PROLACTIN;
D O I
10.1016/0006-8993(93)90069-Y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Using systemic route of administration, the effects of several neurotoxins on hypthalamic tuberoinfundibular dopaminergic neurons were focused in this study. 6-Hydroxydopamine (6-OHDA, 10 or 100 mg/kg b.wt., i.v. or ip) produced a dose (37 vs. 50%)- and time (41 to 29% from day 4 to day 9)-dependent depletion of hypothalamic median eminence dopamine concentrations, and increases of serum prolactin levels in ovariectomized rats. Other central dopaminergic neurons, however, were not significantly affected. Similar treatments with 6-hydroxydopa (6-OHDOPA) were less effective. On the other hand, treatments of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP, 10 mg/kg b.wt./day, ip) for 7 or 14 days produced significant decreases of dihydroxyphenylacetic acid (DOPAC) levels in the median eminence and periventricular regions, and increases in serum prolactin levels. Other central dopaminergic neurons were not significantly affected, though. These results suggest that systemic administration of 6-OHDA, 6-OHDOPA, or MPTP, can produce specific destructive effects on the tuberoinfundibular dopaminergic neurons.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 40 条
[1]   TIME COURSE OF EFFECTS OF 6-HYDROXYDOPAMINE ON CATECHOLAMINE-CONTAINING NEURONES IN RAT HYPOTHALAMUS AND STRIATUM [J].
BELL, LJ ;
IVERSEN, LL ;
URETSKY, NJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1970, 40 (04) :790-&
[2]   DOPAMINE - A PROLACTIN-INHIBITING HORMONE [J].
BENJONATHAN, N .
ENDOCRINE REVIEWS, 1985, 6 (04) :564-589
[3]   REGENERATION OF MONO-AMINERGIC AND CHOLINERGIC NEURONS IN THE MAMMALIAN CENTRAL NERVOUS-SYSTEM [J].
BJORKLUND, A ;
STENEVI, U .
PHYSIOLOGICAL REVIEWS, 1979, 59 (01) :62-100
[4]   REPEATED ADMINISTRATION OF N-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE TO RATS IS NOT TOXIC TO STRIATAL DOPAMINE NEURONS [J].
BOYCE, S ;
KELLY, E ;
REAVILL, C ;
JENNER, P ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (11) :1747-1752
[5]  
BREESE GR, 1970, J PHARMACOL EXP THER, V174, P413
[6]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[7]   THE MECHANISM OF ACTION OF MPTP AND MPP+ ON ENDOGENOUS DOPAMINE RELEASE FROM THE RAT CORPUS STRIATUM SUPERFUSED INVITRO [J].
CHANG, GD ;
RAMIREZ, VD .
BRAIN RESEARCH, 1986, 368 (01) :134-140
[8]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[9]  
CHIUEH CC, 1984, EUR J PHARMACOL, V100, P189, DOI 10.1016/0014-2999(84)90221-8
[10]   LACK OF A HIGH-AFFINITY TRANSPORT-SYSTEM FOR DOPAMINE IN THE MEDIAN-EMINENCE AND POSTERIOR PITUITARY [J].
DEMAREST, KT ;
MOORE, KE .
BRAIN RESEARCH, 1979, 171 (03) :545-551